Skip to main content
When we move cancer drugs from the second or third to the first line of treatment: what lessons can we learn from KEYNOTE-177 and JAVELIN-100
Published Web Location
https://doi.org/10.1136/bmjebm-2021-111702Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.